Advertisement

Topics

Aspreva Pharmaceuticals Corporation Company Profile

12:12 EST 16th December 2018 | BioPortfolio

We are a team of highly motivated, talented and passionate individuals who share the vision of changing the treatment landscape for patients living with a less common disease. Aspreva's vision Aspreva's vision is to change the treatment landscape for people living with less common diseases by increasing the pool of evidence-based medicines available for these patients. What we do Aspreva is focused on addressing the needs of individuals with less common diseases through the identification, development and commercialization of existing medicines for new indications. Aspreva uses a proprietary screening program to identify late stage and approved medicines that show potential for high therapeutic impact in less common diseases. We then partner with pharmaceutical and biopharmaceutical companies to acquire the rights to develop the drug in these new indications, including clinical research and regulatory approvals. Once approved, we apply a strategic and specialized approach to commercializing products for these complex therapeutic categories. Our expertise lies in the clinical, regulatory and commercial development of products for complex diseases and specialized patient populations which differs significantly from traditional pharmaceutical activities. Aspreva is a leader in this new era of pharmaceutical partnering. For more information about our partnerships, please visit the Partners page. For information on our current research, please visit Clinical Trials. Why we do it Aspreva is driven by a desire to enrich the lives of millions of patients worldwide who are affected by less common diseases. We believe we can make a valuable contribution to the management of these diseases by delivering effective, evidence-based treatments. Our partnering strategy enables pharmaceutical and biopharmaceutical companies to develop their drugs, clinically and commercially outside of their products' strategic focus. It is the strength of our partnerships that deliver real benefit to our patients.

Location

#1203,4464 Markham Street
Victoria
V8Z7X8
Canada

Contact

Phone: 1 250 744-2488
Fax: 1 250 744-2498
Email: info@aspreva.com


News Articles [388 Associated News Articles listed on BioPortfolio]

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation cl...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has recei...

Orion Corporation's financial reporting and Annual General Meeting in 2019

ORION CORPORATION          STOCK EXCHANGE RELEASE           18 JULY 2018 at 11.00 EEST                       Orion Corporation's fina...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of t...

International Stem Cell Corporation Developed 3D Liver Structures

CARLSBAD, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage bio...

PubMed Articles [128 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1519 Associated Companies listed on BioPortfolio]

Aspreva Pharmaceuticals Corporation

We are a team of highly motivated, talented and passionate individuals who share the vision of changing the treatment landscape for patients living with a less common disease. Aspreva's vision Asprev...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Acerus Pharmaceuticals Corporation

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, brand...

RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi plat...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Aspreva Pharmaceuticals Corporation" on BioPortfolio

We have published hundreds of Aspreva Pharmaceuticals Corporation news stories on BioPortfolio along with dozens of Aspreva Pharmaceuticals Corporation Clinical Trials and PubMed Articles about Aspreva Pharmaceuticals Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aspreva Pharmaceuticals Corporation Companies in our database. You can also find out about relevant Aspreva Pharmaceuticals Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record